Skip to main content
HCPCS Q2028 · Level II · Part B drug

Q2028: sculptra, HCPCS Level II drug code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: OPPS Addendum B: October 2026 (effective October 1, 2026); OPPS NDC-HCPCS crosswalk: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for Q2028

Billing unit
0.5 mg
Inj, sculptra, 0.5mg
OPPS payment rate
$2.16
no ASP limit; SI K, October 2026
Practitioner MUE
1470
MAI 3
OPPS status
SI K
APC 9095
NCCI exposure
no PTP pairs
Coverage articles
2
6 states

TL;DR

HCPCS Q2028 is the Level II code for Injection, sculptra, 0.5 mg, billed per 0.5 mg. CMS publishes no ASP payment limit for it; hospital outpatient departments are paid separately under OPPS (status indicator K, $2.16 per billing unit in October 2026). The practitioner MUE allows up to 1470 units per date of service (MAI 3). Q2028 is billed in units of 0.5 mg; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. 2 Medicare coverage articles list the code across 6 states, including A58774.

Medicare payment: OPPS rate (no ASP limit)

Q2028 does not appear in the October 2026 Part B ASP payment limit file. CMS pays it separately to hospital outpatient departments under OPPS with status indicator K in APC 9095, at a national unadjusted rate of $2.16 per 0.5 mg. Status K is a separately paid, non-pass-through drug or biological, including therapeutic radiopharmaceuticals. In a physician office the Medicare contractor prices the drug, often from invoice; commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 OPPS crosswalk lists no NDC for Q2028. Report the NDC from the product label and confirm the units conversion from the HCPCS descriptor (Injection, sculptra, 0.5 mg).

Medically Unlikely Edits (MUE)

CMS publishes 2 MUE values for Q2028. For practitioners the limit is 1470 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for Q2028 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services14703 Date of Service Edit: ClinicalClinical: Data
Facility outpatient hospital14703 Date of Service Edit: ClinicalClinical: Data

MUE for Q2028 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists Q2028 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check Q2028 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

Q2028 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

2 current Medicare Administrative Contractor articles list Q2028 in their HCPCS tables, covering 6 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing Q2028
ArticleTitleContractor(s)StatesRelated LCD
A58774Billing and Coding: Cosmetic and Reconstructive SurgeryWisconsin Physicians Service Insurance CorporationIA KS MO NEL39051, L39914
A59299Billing and Coding: Cosmetic and Reconstructive SurgeryCGS Administrators, LLCKY OHL39506

Local coverage policies that list Q2028

2 active Local Coverage Determinations list Q2028 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, Q2028 carries status indicator K and is assigned to APC 9095, with a published national unadjusted payment of $2.16. Status K means the drug is paid separately under OPPS rather than packaged into the procedure.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), Q2028 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $2.16 per 0.5 mg, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for Q2028 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

How QuickIntell checks Q2028 before the claim leaves

QuickCode validates the NDC-to-unit conversion against the current OPPS NDC-HCPCS crosswalk, checks units against every published MUE setting and flags PTP and add-on conflicts on the same claim. QuickRCM routes CARC 16, 151 and 50 denials on drug lines with the matching coverage article attached so the appeal starts with evidence.

Frequently asked questions — HCPCS Q2028

What does HCPCS code Q2028 describe?

Q2028 is defined by CMS as "Injection, sculptra, 0.5 mg". Each billing unit represents 0.5 mg, so the units reported on the claim must equal the dose administered divided by that unit.

Is Q2028 a CPT code?

No. Q2028 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as sculptra; CPT codes are five-character codes maintained by the AMA. On a Part B claim Q2028 reports the drug itself in 0.5 mg units, and the administration is billed on its own line.

What does Medicare pay for Q2028 in a hospital outpatient department?

Q2028 has no Part B ASP limit; the October 2026 OPPS Addendum B pays it separately under status K, APC 9095, at $2.16 per 0.5 mg, and ASC Addendum BB gives it payment indicator K2 at $2.16.

How many units of Q2028 can be billed per day?

The practitioner Medically Unlikely Edit is 1470 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.

Does Q2028 have NCCI bundling edits?

No active practitioner PTP pairs list Q2028 as a column-1 or column-2 code in the v323r0 release.

Which Medicare coverage articles mention Q2028?

2 current Billing and Coding Articles in the Medicare Coverage Database list Q2028, covering 6 states: A58774 (Billing and Coding: Cosmetic and Reconstructive Surgery); A59299 (Billing and Coding: Cosmetic and Reconstructive Surgery).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-10. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.